To ask the Secretary of State for Health and Social Care, when he plans to answer Question 7785 tabled on 26 May 2021 by the hon. Member for Brighton, Pavilion; and what assessment he has made of the implications for his policies of the US Food and Drug Administration warning, issued on 10 June 2021, for the public to stop using the Innova test; if he will (a) specify how much money has been spent on Innova lateral flow tests to date and (b) estimate how much more will be spent on those tests under current contracts; and if he will make a statement.
I refer the hon. Member to the answer I gave on 17 June to Question 7785.
Lateral flow tests used by the United Kingdom, including Innova, receive a rigorous laboratory-based evaluation by a joint Public Health England and University of Oxford team. We are confident that these tests are safe and effective. We are unable to provide the information requested relating to costs as it is commercially sensitive.